Spots Global Cancer Trial Database for diagnostic imaging
Every month we try and update this database with for diagnostic imaging cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer | NCT03939897 | Anatomic Stage ... Metastatic Brea... Metastatic HER2... Metastatic Horm... Recurrent Breas... | Abemaciclib Biopsy Biospecimen Col... Copanlisib Hydr... Diagnostic Imag... Echocardiograph... Fulvestrant Multigated Acqu... | 18 Years - | National Cancer Institute (NCI) | |
| Utility of Anatometabolic Imaging for Radiation Treatment Planning for Lung Cancer | NCT00005666 | Carcinoma, Non-... | PET scan use in... | 0 Years - | National Center for Research Resources (NCRR) | |
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | NCT05512767 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck C... Stage II Hypoph... Stage II Laryng... Stage II Lip an... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Best Practice Consensus Audit... Diagnostic Imag... Lymphedema Mana... Modified Barium... Nasopharyngeal ... Pneumatic Compr... Quality-of-Life... Questionnaire A... Voice Handicap ... | 18 Years - | Mayo Clinic | |
| Moderating the Negative Impact of Abnormal Screening Mammograms | NCT01153126 | Breast Cancer | Comprehensive H... | 18 Years - | University of Wisconsin, Madison | |
| Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia | NCT02981628 | Recurrent B Acu... Recurrent B Lym... Refractory B Ac... Refractory B Ly... | Asparaginase Er... Biospecimen Col... Bone Marrow Asp... Calaspargase Pe... Cyclophosphamid... Cytarabine Diagnostic Imag... Inotuzumab Ozog... Leucovorin Calc... Lumbar Puncture Methotrexate Pegaspargase Vincristine | 1 Year - 21 Years | Children's Oncology Group | |
| Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma | NCT05045027 | Glioma Malignant Gliom... Recurrent Gliom... Recurrent Malig... | Biospecimen Col... Diagnostic Imag... Magnetic Resona... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases | NCT06013423 | Acute Leukemia ... Acute Lymphobla... Acute Myeloid L... Blastic Plasmac... Hematopoietic a... Mixed Phenotype... Myelodysplastic... Myeloproliferat... Non-Hodgkin Lym... Chronic Myeloid... | Biospecimen Col... Bone Marrow Asp... Cyclophosphamid... Cyclosporine Diagnostic Imag... Echocardiograph... Fludarabine Pho... Multigated Acqu... Mycophenolate M... Survey Administ... Thiotepa Total-Body Irra... Umbilical Cord ... | 6 Months - 65 Years | Fred Hutchinson Cancer Center | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes | NCT05687110 | Metastatic Mali... Unresectable Ma... | Biopsy Biospecimen Col... Diagnostic Imag... Novobiocin Sodi... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study | NCT01310699 | Colorectal Neop... Colonic Polyps Colorectal Canc... | Olympus Colonos... | 18 Years - | VA Palo Alto Health Care System | |
| High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy | NCT04461509 | Prostatic Neopl... Genital Neoplas... Urogenital Neop... Neoplasms by Si... Neoplasms Genital Disease... Prostatic Disea... | 18F-PSMA | 18 Years - | Cedars-Sinai Medical Center | |
| Real-Time Characterizations of Diminutive Colorectal Polyps Using Narrow Band Imaging | NCT02441998 | Colorectal Canc... | Education inter... | - | University of Michigan | |
| Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas | NCT06422806 | Stage III Soft ... Stage IV Soft T... Undifferentiate... | Biospecimen Col... Diagnostic Imag... Doxorubicin Echocardiograph... Multigated Acqu... Pembrolizumab | 18 Years - | National Cancer Institute (NCI) | |
| Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals | NCT03125629 | Cancer Diagnosi... Diagnostic Tech... Diagnostic Imag... | F-18 FDG Ga-68-DOTA-TATE Positron Emissi... Positron Emissi... | 18 Years - | Stanford University | |
| Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy | NCT00769093 | Brain Neoplasms | Ferumoxytol | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer | NCT05646316 | Stage I Uterine... | Diagnostic Imag... Indocyanine Gre... Minimally Invas... Pelvic Lymphade... Questionnaire A... Sentinel Lymph ... | 18 Years - | NRG Oncology | |
| PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. | NCT01297088 | Diagnostic Imag... | BAY86-9596 | 30 Years - 80 Years | Life Molecular Imaging SA | |
| Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors | NCT05372640 | Breast Carcinom... Malignant Solid... NUT Carcinoma | Abemaciclib BET Bromodomain... Biopsy Biospecimen Col... Diagnostic Imag... | 12 Years - | National Cancer Institute (NCI) | |
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | NCT05512767 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck C... Stage II Hypoph... Stage II Laryng... Stage II Lip an... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Best Practice Consensus Audit... Diagnostic Imag... Lymphedema Mana... Modified Barium... Nasopharyngeal ... Pneumatic Compr... Quality-of-Life... Questionnaire A... Voice Handicap ... | 18 Years - | Mayo Clinic | |
| Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial | NCT02704520 | Rectal Cancer | High resolution... mrTRG assessmen... | 16 Years - | Imperial College London | |
| Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas | NCT06422806 | Stage III Soft ... Stage IV Soft T... Undifferentiate... | Biospecimen Col... Diagnostic Imag... Doxorubicin Echocardiograph... Multigated Acqu... Pembrolizumab | 18 Years - | National Cancer Institute (NCI) | |
| Cancer Predictive Score on Breast MRI | NCT04914494 | Breast Cancer | 18 Years - | University Hospital, Montpellier | ||
| Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer | NCT06179303 | Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic HER2... Metastatic Horm... | Abemaciclib Anastrozole Biospecimen Col... Computed Tomogr... Diagnostic Imag... Exemestane Fludeoxyglucose... Fluorine F 18 F... Fulvestrant Gonadotropin-re... Letrozole Positron Emissi... Tamoxifen Therapeutic Est... | 18 Years - | University of Washington | |
| Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer | NCT05065736 | Metastatic Canc... Carcinoma Adenocarcinoma | 18F-Clofarabine | 18 Years - | Case Comprehensive Cancer Center | |
| Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals | NCT03125629 | Cancer Diagnosi... Diagnostic Tech... Diagnostic Imag... | F-18 FDG Ga-68-DOTA-TATE Positron Emissi... Positron Emissi... | 18 Years - | Stanford University | |
| The Canada Lymph Node Score: A Feasibility Randomized Controlled Trial | NCT03859349 | Non Small Cell ... | Selective Targe... Systematic Samp... | 18 Years - | St. Joseph's Healthcare Hamilton | |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors | NCT04616534 | Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation | NCT01260480 | Carcinoma, Non-... Head and Neck N... | [18F]-ML-10 in ... | 18 Years - | Aposense Ltd. | |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines | NCT04535401 | Advanced Colore... Advanced Digest... Advanced Gastri... Advanced Gastro... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Metastatic Colo... Metastatic Dige... Metastatic Gast... Metastatic Gast... Stage III Color... Stage IV Colore... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Fluorouracil Irinotecan Hydr... Leucovorin Calc... | 18 Years - | National Cancer Institute (NCI) | |
| Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer | NCT01767961 | Oropharyngeal C... | diagnostic imag... questionnaire a... quality-of-life... | 40 Years - 89 Years | Wake Forest University Health Sciences | |
| Early Detection of Breast Cancer Using Tomosynthesis Imaging | NCT00637598 | Breast Neoplasm... | Mammography and... | - | Duke University | |
| Neurotoxicity in Primary Central Nervous System Lymphoma (PCNSL): An International Observational Study of Cognition in Long Term Survivors | NCT00710151 | Primary Central... | 18 Years - 75 Years | OHSU Knight Cancer Institute | ||
| The Digital Breast Tomosynthesis Trial in Bergen | NCT02835625 | Breast Neoplasm... | Synthetic Mammo... Digital mammogr... | 48 Years - 71 Years | Cancer Registry of Norway | |
| Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation | NCT00659334 | Brain Neoplasms | Ferumoxtran-10 ... Neurosurgery | 5 Years - 75 Years | OHSU Knight Cancer Institute | |
| Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI | NCT01067976 | Breast Cancer Diagnostic Imag... | Gadobutrol (Gad... | 18 Years - | Bayer | |
| Augmented Reality Headset as Adjunct Display Monitor in AMIGO | NCT03328416 | Malignancy Infection Pain | Augmented Reali... | 18 Years - | Brigham and Women's Hospital | |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors | NCT04616534 | Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| Real-Time Characterizations of Diminutive Colorectal Polyps Using Narrow Band Imaging | NCT02441998 | Colorectal Canc... | Education inter... | - | University of Michigan | |
| Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer | NCT03327883 | Bladder Cancer | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) Inflammation | NCT00659334 | Brain Neoplasms | Ferumoxtran-10 ... Neurosurgery | 5 Years - 75 Years | OHSU Knight Cancer Institute | |
| Micro-Ultrasound/Magnetic Resonance Imaging 001 | NCT03938376 | Diagnoses Disea... | Micro-Ultrasoun... | - | University Health Network, Toronto | |
| Beyond TME Origins | NCT02292641 | Neoplasms Adenocarcinoma Carcinoma | New Radiologica... | 16 Years - | Imperial College London | |
| The Tomosynthesis Trial in Bergen - Part 2 | NCT03669926 | Breast Neoplasm... | Digital Breast ... | 48 Years - 71 Years | Cancer Registry of Norway | |
| The Canada Lymph Node Score: A Feasibility Randomized Controlled Trial | NCT03859349 | Non Small Cell ... | Selective Targe... Systematic Samp... | 18 Years - | St. Joseph's Healthcare Hamilton | |
| Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance | NCT02171078 | Breast Neoplasm... | - | University of Wisconsin, Madison | ||
| NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | NCT04539808 | Pancreatic Aden... Stage 0 Pancrea... Stage I Pancrea... Stage III Pancr... Stage IV Pancre... | Capecitabine Fluorouracil Irinotecan Hydr... Leucovorin Calc... Losartan Potass... Oxaliplatin Radiation Thera... Resection Diagnostic Imag... Biospecimen Col... | 18 Years - | OHSU Knight Cancer Institute | |
| Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors | NCT04616534 | Advanced Fallop... Advanced Malign... Advanced Ovaria... Advanced Pancre... Advanced Primar... Fallopian Tube ... Metastatic Panc... Ovarian High Gr... Platinum-Resist... Platinum-Resist... Platinum-Resist... Primary Periton... Stage II Pancre... Stage III Fallo... Stage III Ovari... Stage III Pancr... Stage III Prima... Stage IV Fallop... Stage IV Ovaria... Stage IV Pancre... Stage IV Primar... Unresectable Pa... | Biopsy Biospecimen Col... Diagnostic Imag... Elimusertib Gemcitabine | 18 Years - | National Cancer Institute (NCI) | |
| Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer | NCT04014231 | Malignant Neopl... | Diagnostic Imag... Laboratory Biom... | 18 Years - | City of Hope Medical Center | |
| Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial | NCT05327010 | Advanced Malign... Metastatic Mali... Unresectable Ma... | BET Bromodomain... Biopsy Biospecimen Col... Diagnostic Imag... Talazoparib | 18 Years - | National Cancer Institute (NCI) | |
| Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer | NCT01767961 | Oropharyngeal C... | diagnostic imag... questionnaire a... quality-of-life... | 40 Years - 89 Years | Wake Forest University Health Sciences | |
| PCI Imaging System in Pediatric Ophthalmology | NCT02617862 | Retinoblastoma | Examination und... RetCam COSMOS | - | The Hospital for Sick Children | |
| Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy | NCT00769093 | Brain Neoplasms | Ferumoxytol | 18 Years - 75 Years | OHSU Knight Cancer Institute | |
| Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors | NCT05372640 | Breast Carcinom... Malignant Solid... NUT Carcinoma | Abemaciclib BET Bromodomain... Biopsy Biospecimen Col... Diagnostic Imag... | 12 Years - | National Cancer Institute (NCI) | |
| Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma | NCT00068146 | Lymphoprolifera... Lymphoma | 8 Years - | National Institutes of Health Clinical Center (CC) | ||
| PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers | NCT01287845 | Diagnostic Imag... | BAY1075553 BAY1075553 | 18 Years - | Life Molecular Imaging SA | |
| Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping | NCT05389085 | Skin Cancer Malignant Melan... | Reflectance con... | 18 Years - | University Hospital Bispebjerg and Frederiksberg | |
| High Resolution PET-MRI Before Prostate Cancer HIFU | NCT03263780 | Prostate Cancer | 18F-Fluciclovin... | 18 Years - | Cedars-Sinai Medical Center | |
| Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer | NCT04478669 | Invasive Breast... Mastectomy, Seg... Margins of Exci... | 19 Years - | Aarhus University Hospital | ||
| High Resolution PET-MRI Before Prostate Cancer HIFU | NCT03263780 | Prostate Cancer | 18F-Fluciclovin... | 18 Years - | Cedars-Sinai Medical Center | |
| Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI) | NCT01104584 | Breast Cancer | Gadobutrol (Gad... | 18 Years - | Bayer | |
| Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer | NCT06179303 | Anatomic Stage ... Anatomic Stage ... Locally Advance... Locally Advance... Metastatic HER2... Metastatic Horm... | Abemaciclib Anastrozole Biospecimen Col... Computed Tomogr... Diagnostic Imag... Exemestane Fludeoxyglucose... Fluorine F 18 F... Fulvestrant Gonadotropin-re... Letrozole Positron Emissi... Tamoxifen Therapeutic Est... | 18 Years - | University of Washington | |
| A Pneumatic Compression Device for the Treatment of Lymphedema in Patients With Stage II-IV Head and Neck Cancer After Chemoradiation | NCT05512767 | Clinical Stage ... Clinical Stage ... Clinical Stage ... Head and Neck C... Stage II Hypoph... Stage II Laryng... Stage II Lip an... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Lip a... Stage III Oroph... Stage IV Hypoph... Stage IV Laryng... Stage IV Lip an... Stage IV Oropha... | Best Practice Consensus Audit... Diagnostic Imag... Lymphedema Mana... Modified Barium... Nasopharyngeal ... Pneumatic Compr... Quality-of-Life... Questionnaire A... Voice Handicap ... | 18 Years - | Mayo Clinic | |
| Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation | NCT00001523 | Radiation Injur... Xerostomia | - | National Institutes of Health Clinical Center (CC) | ||
| Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping | NCT05389085 | Skin Cancer Malignant Melan... | Reflectance con... | 18 Years - | University Hospital Bispebjerg and Frederiksberg | |
| Virtual Reality in Imaging Review for Cancer Patients | NCT04469478 | Patient Educati... Virtual Reality Diagnostic Imag... Cancer Patient | Survey and inte... | 18 Years - | University of Colorado, Denver | |
| Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer | NCT05411094 | Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa... | Biopsy Biospecimen Col... Diagnostic Imag... Durvalumab Olaparib Radiation Thera... | 18 Years - | National Cancer Institute (NCI) | |
| Augmented Reality Headset as Adjunct Display Monitor in AMIGO | NCT03328416 | Malignancy Infection Pain | Augmented Reali... | 18 Years - | Brigham and Women's Hospital | |
| Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer | NCT04478669 | Invasive Breast... Mastectomy, Seg... Margins of Exci... | 19 Years - | Aarhus University Hospital | ||
| Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer | NCT05065736 | Metastatic Canc... Carcinoma Adenocarcinoma | 18F-Clofarabine | 18 Years - | Case Comprehensive Cancer Center | |
| Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer | NCT04478669 | Invasive Breast... Mastectomy, Seg... Margins of Exci... | 19 Years - | Aarhus University Hospital | ||
| The Digital Breast Tomosynthesis Trial in Bergen | NCT02835625 | Breast Neoplasm... | Synthetic Mammo... Digital mammogr... | 48 Years - 71 Years | Cancer Registry of Norway | |
| Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors | NCT05372640 | Breast Carcinom... Malignant Solid... NUT Carcinoma | Abemaciclib BET Bromodomain... Biopsy Biospecimen Col... Diagnostic Imag... | 12 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
